BeOne Medicines Ltd.
ONC
58 insider filings · Latest: Oct 13, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jul 30, 2026 | Jul 30 9:34 PM | CHAN LEE | Proposed Sale | 1,044 | $323.69 | $337.9K | — | View → |
| Jul 22, 2026 | Jul 24 8:51 PM | Chan Henry LeeSVP, General Counsel | Sale | 1,669 | $325.00 | $542.4K | 0(D) | View → |
| Jul 21, 2026 | Jul 22 9:03 PM | John OylerDirector, Chief Executive Officer | Sale | 61,397 | $317.67 | $19.5M | 0(D) | View → |
| Jul 20, 2026 | Jul 22 9:03 PM | John OylerDirector, Chief Executive Officer | Sale | 48,316 | $312.25 | $15.1M | 0(D) | View → |
| Jul 22, 2026 | Jul 22 8:29 PM | CHAN LEE | Proposed Sale | 2,001 | $318.69 | $637.7K | — | View → |
| Jul 17, 2026 | Jul 17 9:36 PM | John OylerDirector, Chief Executive Officer | Sale | 64,628 | $312.00 | $20.2M | 0(D) | View → |
| Jul 16, 2026 | Jul 17 9:31 PM | John OylerDirector, Chief Executive Officer | Sale | 166,597 | $318.09 | $53.0M | 0(D) | View → |
| Jul 15, 2026 | Jul 17 9:31 PM | John OylerDirector, Chief Executive Officer | Sale | 116,557 | $311.95 | $36.4M | 0(D) | View → |
| Jul 14, 2026 | Jul 15 1:26 AM | John OylerDirector, Chief Executive Officer | Sale | 145,861 | $305.95 | $44.6M | 0(D) | View → |
| Jul 13, 2026 | Jul 15 1:25 AM | John OylerDirector, Chief Executive Officer | Sale | 48,520 | $304.35 | $14.8M | 0(D) | View → |
| Jul 10, 2026 | Jul 15 1:25 AM | John OylerDirector, Chief Executive Officer | Sale | 11,698 | $298.34 | $3.5M | 0(D) | View → |
| Jul 14, 2026 | Jul 14 8:48 PM | JOHN V OYLER | Proposed Sale | 513,574 | $303.96 | $156.1M | — | View → |
| Jul 8, 2026 | Jul 10 8:44 PM | Chan Henry LeeSVP, General Counsel | Sale | 664 | $302.46 | $200.8K | 0(D) | View → |
| Jul 10, 2026 | Jul 10 8:36 PM | JOHN V OYLER | Proposed Sale | 150,000 | $302.83 | $45.4M | — | View → |
| Jul 10, 2026 | Jul 10 8:35 PM | PAN-OYLER FOUNDATION | Proposed Sale | 49,541 | $302.83 | $15.0M | — | View → |
| Jun 23, 2026 | Jun 25 9:15 PM | Xiaobin WuPresident and COO | Sale | 1,292 | $276.26 | $356.9K | 0(D) | View → |
| Jun 23, 2026 | Jun 25 9:15 PM | John OylerDirector, Chief Executive Officer | Sale | 3,410 | $273.78 | $933.6K | 0(D) | View → |
| Jun 23, 2026 | Jun 25 9:14 PM | Lai WangPresident, Global Head of R&D | Sale | 1,068 | $276.74 | $295.6K | 0(D) | View → |
| Jun 23, 2026 | Jun 23 8:24 PM | LAI WANG | Proposed Sale | 1,068 | $276.74 | $295.6K | — | View → |
| Jun 23, 2026 | Jun 23 8:21 PM | XIAOBIN WU | Proposed Sale | 1,292 | $276.26 | $356.9K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Oct 13, 2026 | Oct 15 9:08 PM | Xiaodong WangDirector, Other | Option Exercise | 403,351 | — | 403,364(D) | View → |
| Sep 28, 2026 | Sep 30 9:11 PM | Xiaodong WangDirector, Other | Option Exercise | 403,364 | — | 806,715(D) | View → |
| Sep 8, 2026 | Sep 10 8:49 PM | Xiaodong WangDirector, Other | Option Exercise | 403,351 | — | 1,210,079(D) | View → |
| Aug 11, 2026 | Aug 14 12:54 AM | Chan Henry LeeSVP, General Counsel | Option Exercise | 34,658 | — | 88,582(D) | View → |
| Jul 22, 2026 | Jul 24 8:51 PM | Chan Henry LeeSVP, General Counsel | Option Exercise | 21,697 | — | 98,930(D) | View → |
| Jul 20, 2026 | Jul 22 9:03 PM | John OylerDirector, Chief Executive Officer | Option Exercise | 441,870 | — | 0(D) | View → |
| Jul 17, 2026 | Jul 17 9:36 PM | John OylerDirector, Chief Executive Officer | Option Exercise | 840,164 | — | 441,870(D) | View → |
| Jul 16, 2026 | Jul 17 9:31 PM | John OylerDirector, Chief Executive Officer | Option Exercise | 2,165,761 | — | 1,282,034(D) | View → |
| Jul 15, 2026 | Jul 17 9:31 PM | John OylerDirector, Chief Executive Officer | Option Exercise | 1,515,241 | — | 1,254,513(D) | View → |
| Jul 14, 2026 | Jul 15 1:26 AM | John OylerDirector, Chief Executive Officer | Option Exercise | 1,736,800 | — | 462,866(D) | View → |
| Jul 13, 2026 | Jul 15 1:25 AM | John OylerDirector, Chief Executive Officer | Option Exercise | 630,760 | — | 1,264,666(D) | View → |
| Jul 10, 2026 | Jul 15 1:25 AM | John OylerDirector, Chief Executive Officer | Option Exercise | 152,074 | — | 1,895,426(D) | View → |
| Jul 8, 2026 | Jul 10 8:44 PM | Chan Henry LeeSVP, General Counsel | Option Exercise | 8,632 | — | 105,300(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Lai WangPresident, Global Head of R&D | Grant/Award | 229,775 | — | 229,775(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Aaron RosenbergChief Financial Officer | Grant/Award | 137,865 | — | 137,865(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Xiaobin WuPresident and COO | Grant/Award | 229,775 | — | 229,775(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Chan Henry LeeSVP, General Counsel | Grant/Award | 87,308 | — | 87,308(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | John OylerDirector, Chief Executive Officer | Grant/Award | 344,669 | — | 344,669(D) | View → |
| Jun 11, 2026 | Jun 15 9:54 PM | Xiaodong WangDirector, Other | Grant/Award | 193,492 | — | 193,492(D) | View → |
| May 13, 2026 | May 15 8:39 PM | Chan Henry LeeSVP, General Counsel | Option Exercise | 4,316 | — | 107,848(D) | View → |
Page 1 of 2
Next →